甲状腺毒性周期性:诊断和管理方面的考虑
Fahad S Alrashedi1, Raghad A Alonazi2
1Internal medicine department, Nephrology section, Ad diriyah hospital, Third riyadh health cluster, Riyadh, Saudi Arabia dr-fsr@hotmail.com.
BMJ case reports
|December 12, 2025
概括
甲状腺毒性周期性,甲状腺毒性病的罕见并发症,由于低,导致突然虚弱. 及时补充和治疗潜在的甲状腺疾病有效地恢复了肌肉力量.
科学领域:
- 内分泌学 在内分泌学.
- 神经学 神经学
- 内部医学 内部医学
背景情况:
- 甲状腺毒性周期性 (TPP) 是甲状腺毒性病的罕见,可能危及生命的并发症.
- 它的特征是由于细胞内转移而引起的低血诱导的软性麻.
研究的目的:
- 报告一个菲律宾裔中年男性的TPP病例.
- 突出TPP的诊断特征和管理.
主要方法:
- 一份病例报告,详细介绍患者的表现,临床发现和实验室结果.
- 管理涉及静脉注射的化,醇和甲基马.
主要成果:
- 患者出现了急性双侧下肢虚弱和严重的低血 (1.7 mmol/L).
- 电脑心电图显示了鼻高心率,AV阻塞和U波. 甲状腺面板显示了抑制的TSH,FT4/FT3.3升高.
- 肌肉力量在治疗后24小时内恢复正常.
结论:
- TPP诊断得到了低血没有酸性疾病的支持,适当的保存和特征性的心电图变化.
- 有效的管理需要迅速补充,β阻塞,并最终治疗甲状腺毒性病,以防止复发.
相关概念视频
Myasthenia Gravis: Diagnostic Tests
1.8K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.8K
Pericarditis III: Medical Management
281
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
281
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
421
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
421
Dysrhythmias V: Evaluating Dysrhythmias
311
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
311
Myocarditis III: Medical Management
160
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
160
Myasthenia Gravis: Overview and Treatment
2.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.7K


